While the reduction in price target could suggest a more conservative outlook on Natera's future growth or valuation, the maintenance of an Overweight rating implies that Morgan Stanley still sees the stock as a good investment relative to the market or sector. The impact on the stock price is likely to be neutral in the short term as the reduction in target price is minimal and does not change the overall positive stance.